SCHEMBL29948948

SCHEMBL29948948

N#Cc1cc(F)ccc1S(=O)(=O)Cl

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 4/20 0.46
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HTR2A P28223 3/20 0.37
HTR2C P28335 3/20 0.37
KCNH2 Q12809 2/20 0.37
TDO2 P48775 1/20 0.37
SLC22A12 Q96S37 4/20 0.36
USP8 P40818 1/20 0.35
USP7 Q93009 1/20 0.35
USP47 Q96K76 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
DRD2 P14416 1/20 0.33
EPAS1 Q99814 1/20 0.33
PTGS2 P35354 1/20 0.33
RORC P51449 1/20 0.33
PPME1 Q9Y570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16080223 1.00 TRPV4 (0.46) TRPV4MEN1KMT2AHTR2AHTR2C
SCHEMBL12777966 0.85 TRPV4 (0.42) TRPV4MEN1KMT2AHTR2AHTR2C
SCHEMBL1556216 0.83 TDO2 (0.43) TRPV4MEN1KMT2ATDO2PTGES2
SCHEMBL26598944 0.81 CA12 (0.46) MEN1KMT2AHTR2AHTR2CKCNH2
SCHEMBL29212553 0.81 EPAS1 (0.44) MEN1KMT2AHTR2AHTR2CKCNH2
SCHEMBL7765655 0.79 TRPV4 (0.60) TRPV4SLC22A12PTGES2
SCHEMBL19682467 0.79 TRPV4 (0.49) TRPV4MEN1KMT2ASLC22A12
SCHEMBL28069903 0.79 EPAS1 (0.44) EPAS1
SCHEMBL711705 0.78 TRPV4 (0.42) TRPV4SLC22A12
SCHEMBL19682468 0.78 TRPV4 (0.43) TRPV4SLC22A12USP8USP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612131-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2025-09-10 EP disclosed
WO-2024095003-A1 NICOTINAMIDE DERIVATIVES FOR USE IN TREATING DISORDERS ASSOCIATED WITH KCNK13 ACTIVITY Cerevance, Inc. (US) 2024-05-10 WO disclosed
EP-4061124-A1 TRPV4 RECEPTOR LIGANDS University of Utah Research Foundation (US) 2022-09-28 EP disclosed